Approaches to implement bispecific antibody treatment of ovarian carcinoma

Event-related potential markers of subjective cognitive decline and mild cognitive impairment during a sustained visuo-attentive task.

NeuroImage. Clinical·2025

Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trial.

ESMO open·2025

Toward the Development of User-Centered Neurointegrated Lower Limb Prostheses.

IEEE reviews in biomedical engineering·2023

Progress in Dental Adhesive Materials.

Journal of dental research·2023

Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial.

ESMO open·2022

Microbial contamination of resin composites inside their dispensers: An increased risk of cross-infection?

Journal of dentistry·2021

The effect and mechanism of TIPE in promoting M2 polarization through DcR3 in the microenvironment of colorectal cancer.

Cancer immunology, immunotherapy : CII·2026

Neoadjuvant combined immunotherapy with intratumoral TransCon TLR7/8 Agonist and systemic TransCon IL-2 β/y or pembrolizumab in patients with locally advanced oral cancer-a monocentric experience.

Cancer immunology, immunotherapy : CII·2026

The CREM-IL-15 axis: decoding the persistence-exhaustion paradox in NK cell immunotherapy.

Cancer immunology, immunotherapy : CII·2026

Dual inhibition of tumor cells and tumor-associated neutrophils by anti-CXCR2 antibodies suppresses tumor growth and augments immunotherapy efficacy in ARID1A-deficient pancreatic cancer.

Cancer immunology, immunotherapy : CII·2026

Therapeutic targeting of CD47 using a tri-specific NK cell engager to inhibit multiple myeloma.

Cancer immunology, immunotherapy : CII·2026

Mast cells in tumors: dual roles and therapeutic potential.

Cancer immunology, immunotherapy : CII·2026

Biological effects of N-acetylcysteine, calcium hydroxide, chlorhexidine and their combinations as intracanal medications: cytotoxicity, genotoxicity and cytokine modulation.

BDJ open·2026

Clinical Determinants Influencing First-line Immune Checkpoint Inhibitor Selection for Unresectable Hepatocellular Carcinoma in Japan.

Anticancer research·2026

Comparing the real-world effectiveness of oral corticosteroids and antifungals for the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.

Chest·2026

Unravelling the synergistic potential of Olibanum extract and Bacillus clausii in combating intestinal cryptosporidiosis in immunosuppressed mice.

PLoS neglected tropical diseases·2026

Bifunctional Nanozymes for Synergistic Treatment by Boosting Oxidative Stress and Regulating the Protein Kinase B Pathway.

ACS nano·2026

SRPK Inhibition in Cholangiocarcinoma Cells Induces LAMB1-Associated Adaptive Responses and Enhances Growth Suppression by the MEK Inhibitor U0126 via the LAMB1/ERK/c-JUN Axis.

Frontiers in bioscience (Landmark edition)·2026

Related Experiment Videos

Approaches to implement bispecific antibody treatment of ovarian carcinoma

Related Concept Videos

Event-related potential markers of subjective cognitive decline and mild cognitive impairment during a sustained visuo-attentive task.

Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trial.

Toward the Development of User-Centered Neurointegrated Lower Limb Prostheses.

Progress in Dental Adhesive Materials.

Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial.

Microbial contamination of resin composites inside their dispensers: An increased risk of cross-infection?

The effect and mechanism of TIPE in promoting M2 polarization through DcR3 in the microenvironment of colorectal cancer.

Neoadjuvant combined immunotherapy with intratumoral TransCon TLR7/8 Agonist and systemic TransCon IL-2 β/y or pembrolizumab in patients with locally advanced oral cancer-a monocentric experience.

The CREM-IL-15 axis: decoding the persistence-exhaustion paradox in NK cell immunotherapy.

Dual inhibition of tumor cells and tumor-associated neutrophils by anti-CXCR2 antibodies suppresses tumor growth and augments immunotherapy efficacy in ARID1A-deficient pancreatic cancer.

Therapeutic targeting of CD47 using a tri-specific NK cell engager to inhibit multiple myeloma.

Mast cells in tumors: dual roles and therapeutic potential.

Biological effects of N-acetylcysteine, calcium hydroxide, chlorhexidine and their combinations as intracanal medications: cytotoxicity, genotoxicity and cytokine modulation.

Clinical Determinants Influencing First-line Immune Checkpoint Inhibitor Selection for Unresectable Hepatocellular Carcinoma in Japan.

Comparing the real-world effectiveness of oral corticosteroids and antifungals for the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.

Unravelling the synergistic potential of Olibanum extract and Bacillus clausii in combating intestinal cryptosporidiosis in immunosuppressed mice.

Bifunctional Nanozymes for Synergistic Treatment by Boosting Oxidative Stress and Regulating the Protein Kinase B Pathway.

SRPK Inhibition in Cholangiocarcinoma Cells Induces LAMB1-Associated Adaptive Responses and Enhances Growth Suppression by the MEK Inhibitor U0126 via the LAMB1/ERK/c-JUN Axis.

Related Experiment Videos

Approaches to implement bispecific antibody treatment of ovarian carcinoma

Related Concept Videos

Related Articles